Sign in

Private company

Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc. is a Canadian pharmaceutical preparations company based in Totronto.2

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersTotronto, Canada2
  • Incorporated inOntario, Canada3
  • Business address30 Worcester Road, Toronto, A6 M9W 5X23
  • Filer categoryNon-accelerated filer3
  • Legal formBusiness corporations (which includes professional corporations)2
  • LEI529900G23JHRE3XDSC032
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address30 Worcester Road, M9W 5X2 Totronto, Canada2
  • Registered withCorporations Canada, 452861-12

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-4336.8%Operating margin4
-4400.6%Net margin4
-$1.4MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development72¢$2.1M
  • Selling, general and admin19¢$561.0K
  • Interest10¢$291.6K

Out of $65.7K in revenue.4 The company lost money this year.

Financial statements

Revenue5674$65.7K in 2022−99% since 2017
0$2.0M$4.0M$6.0M2017: $5.5M$5.5M20172018: $1.7M$1.7M2018−69%2019: $3.5M$3.5M2019+103%2020: $1.4M$1.4M2020−60%2021: $0$020212022: $65.7K$65.7K2022
Gross profit567$0 in 2021
0$2.0M$4.0M$6.0M2017: $4.8M$4.8M20172018: $1.6M$1.6M2018−67%2019: $3.4M$3.4M2019+117%2020: $1.4M$1.4M2020−59%2021: $0$02021
Operating income5674-$2.9M in 2022−66% since 2017
-$15.0M-$10.0M-$5.0M02017: -$8.3M-$8.3M20172018: -$13.3M-$13.3M2018+61%2019: -$7.8M-$7.8M2019−41%2020: -$4.7M-$4.7M2020−40%2021: -$4.2M-$4.2M2021−11%2022: -$2.9M-$2.9M2022−32%
Net income5674-$2.9M in 2022−67% since 2017
-$15.0M-$10.0M-$5.0M02017: -$8.9M-$8.9M20172018: -$13.7M-$13.7M2018+55%2019: -$8.1M-$8.1M2019−41%2020: -$3.4M-$3.4M2020−58%2021: -$5.1M-$5.1M2021+52%2022: -$2.9M-$2.9M2022−44%
Fiscal year2016201720182019202020212022
Revenue$5.5M5$1.7M6$3.5M7$1.4M4$04$65.7K4
Cost of revenue0 CAD8$704.0K5$124.9K6$33.1K7$07$07
Gross profit$4.8M5$1.6M6$3.4M7$1.4M7$07
Research and development$9.3M5$10.8M6$6.6M7$3.5M4$2.7M4$2.1M4
Selling, general and admin$3.3M5$3.5M6$4.2M7$2.1M4$1.2M4$561.0K4
Operating expenses$4.2M4$2.9M4
Operating income-$8.3M5-$13.3M6-$7.8M7-$4.7M4-$4.2M4-$2.9M4
Interest$389.2K5$255.2K6$247.5K7$969.7K4$549.3K4$291.6K4
Income before tax-$5.3M4-$2.9M4
Income tax$05$06$8.1M7$3.4M7-$5.1M7
Net income-$8.9M5-$13.7M6-$8.1M7-$3.4M4-$5.1M4-$2.9M4

Compare Intellipharmaceutics International Inc. with another company

Corporate structure

Intellipharmaceutics International Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Intellipharmaceutics International Inc.

  • ARMISTICE CAPITAL, LLC Filed SC 13G/A on Intellipharmaceutics International Inc., latest Feb 14, 2024 (3 filings since Feb 15, 2022)
  • Intellipharmaceutics International Inc. Totronto, Ontario, Canada

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Intellipharmaceutics International Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$7.5M4 Nov 30, 2022$7.5M4 Nov 30, 20210%
Accumulated depreciation$6.7M4 Nov 30, 2022$6.5M4 Nov 30, 2021+3.2%
Property and equipment, net$788.0K4 Nov 30, 2022$994.1K4 Nov 30, 2021−20.7%
Operating-lease assets (leased space)$151.5K4 Nov 30, 2022$04 Nov 30, 2021

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$83.7K4 Nov 30, 2022$771.9K4 Nov 30, 2021−89.2%

Inventory

ItemLatestA year beforeChange
Inventory, total$07 Nov 30, 2021$112.7K7 Nov 30, 2020−100.0%
Raw materials$07 Nov 30, 2021$112.7K7 Nov 30, 2020−100.0%
Work in process$07 Nov 30, 2021$07 Nov 30, 2020
Finished goods$07 Nov 30, 2021$07 Nov 30, 2020

Filings

35 filings to the SEC since October 2021: 4 annual reports, 3 large holders, 28 other. The latest 20:

  1. Jun 14, 20246-K EDGAR
  2. Apr 3, 2024NT 20-F EDGAR
  3. Mar 14, 20246-K EDGAR
  4. Mar 7, 20246-K EDGAR
  5. Feb 27, 20246-K EDGAR
  6. Feb 14, 2024SC 13G/A EDGAR
  7. Feb 14, 2024UPLOAD EDGAR
  8. Feb 9, 20246-K EDGAR
  9. Feb 6, 202420-F/A EDGAR
  10. Jan 12, 20246-K EDGAR
  11. Nov 8, 2023CORRESP EDGAR
  12. Oct 16, 20236-K EDGAR
  13. Oct 6, 20236-K EDGAR
  14. Oct 6, 20236-K EDGAR
  15. Sep 26, 20236-K EDGAR
  16. Sep 26, 20236-K EDGAR
  17. Sep 8, 2023UPLOAD EDGAR
  18. Jun 14, 202320-F EDGAR
  19. Feb 14, 2023SC 13G/A EDGAR
  20. Oct 14, 20226-K EDGAR

The 35 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Intellipharmaceutics International Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARIntellipharmaceutics International Inc.1
  • CIK0001474835
  • Filer statusNon-accelerated filer1
  • Incorporated inOntario, Canada1
  • Fiscal year endsNovember 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address30 Worcester Road, Toronto, A6 M9W 5X21
  • Phone416-798-30011
  • Shares outstanding33,092,665 as of Jun 10, 20234
  • On EDGAR sinceOct 22, 20091
  • Filings473 in all: 6-K (294), 424B3 (61), SC 13G/A (21), 424B5 (15), 20-F (14), SC 13G (11), CORRESP (6), EFFECT (6)1
    All 25 form types

    SC 13D/A (6), UPLOAD (6), 20-F/A (5), D (4), F-1/A (4), F-3 (4), F-3/A (4), CT ORDER (2), F-1 (2), 25-NSE (1), 424B4 (1), 6-K/A (1), 8-K12G3 (1), F-1MEF (1), FWP (1), NT 20-F (1), SC 13D (1)

  • Latest filingsAnnual report (20-F) Jun 14, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10